Bill HB20-1065

HB20-1065

Harm Reduction Substance Use Disorders

Concerning the use of measures that do not involve schedule I controlled substances to reduce the harm caused by substance use disorders.

SESSION: 2020 Regular Session

SUBJECT: Public Health

BILL SUMMARY

The act:

Requires a carrier that provides coverage for opiate antagonists to reimburse a hospital if the hospital provides a covered person with an opiate antagonist upon discharge;
Requires a pharmacist who dispenses a prescription for an opioid to notify the individual to whom the opioid is being dispensed about the availability of an opiate antagonist;
Allows a pharmacist or pharmacy technician to sell a nonprescription syringe or needle to any person and exempts pharmacists and pharmacy technicians who sell nonprescription syringes or needles from the drug paraphernalia criminal statutes;
Extends civil and criminal immunity for a person who acts in good faith to furnish or administer an opiate antagonist to an individual the person believes to be suffering an opiate-related drug overdose when the opiate antagonist was expired; and
Allows a nonprofit organization to operate a clean syringe exchange program without local board of health approval and requires the nonprofit organization to annually report specified information to the department of public health and environment. (Note: This summary applies to this bill as enacted.)